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Abstract
Alcohol use disorders (AUD) are common conditions that have enormous social and economic 
consequences. We obtained quantitative measures using the Alcohol Use Disorder Identification 
Test (AUDIT) from two population-based cohorts of European ancestry: UK Biobank (UKB; 
N=121,604) and 23andMe (N=20,328) and performed a genome-wide association study (GWAS) 
meta-analysis. We also performed GWAS for AUDIT items 1–3, which focus on consumption 
(AUDIT-C), and for items 4–10, which focus on the problematic consequences of drinking 
(AUDIT-P). The GWAS meta-analysis of AUDIT total score identified 10 associated risk loci. 
Novel associations localized to genes including JCAD and SLC39A13; we also replicated 
previously identified signals in the genes ADH1B, ADH1C, KLB, and GCKR. The dimensions of 
AUDIT showed positive genetic correlations with alcohol consumption (rg=0.76–0.92) and 
Diagnostic and Statistical Manual of Mental Disorders (DSM-IV) alcohol dependence (rg=0.33–
0.63). AUDIT-P and AUDIT-C showed significantly different patterns of association across a 
number of traits, including psychiatric disorders. AUDIT-P was positively genetically correlated 
with schizophrenia (rg=0.22, p=3.0×10−10), major depressive disorder (rg=0.26, p=5.6×10−3), 
and attention-deficit/hyperactivity disorder (ADHD; rg=0.23, p=1.1×10−5), whereas AUDIT-C 
was negatively genetically correlated with major depressive disorder (rg=−0.24, p=3.7×10−3) and 
ADHD (rg=−0.10, p=1.8×10−2). We also used the AUDIT data in the UKB to identify thresholds 
for dichotomizing AUDIT total score that optimize genetic correlations with DSM-IV alcohol 
dependence. Coding individuals with AUDIT total score of ≤4 as controls and ≥12 as cases 
produced a high genetic correlation with DSM-IV alcohol dependence (rg=0.82, p=3.2×10−6) 
while retaining most subjects. We conclude that AUDIT scores ascertained in population-based 
cohorts can be used to explore the genetic basis of both alcohol consumption and AUD.
Introduction
Alcohol use disorders (AUD) are modestly heritable, with twin-studies demonstrating that 
approximately 50% of the phenotypic variance is attributed to genetic factors (1, 2). To date, 
genetic studies of AUD have identified genes that influence pharmacokinetic (e.g. ADH1B, 
ADH1C, ALDH2)(3–8), but not pharmacodynamic factors. The difficulty of assembling 
large, carefully diagnosed cohorts of AUD has stimulated additional studies of non-clinical 
phenotypes, such as alcohol consumption, in populations not ascertained for alcohol 
dependence. This approach has allowed for the relatively rapid collection of much larger 
sample sizes (e.g. >100,000s individuals) and has identified numerous loci associated with 
both pharmacokinetic and pharmacodynamic factors that influence alcohol consumption, 
including ADH1B/ADH1C/ADH5 (9–11), KLB (encoding β-klotho)(9, 11, 12) and GCKR, 
encoding the glucokinase regulatory protein (9, 11). However, the genetic overlap between 
alcohol consumption (units per week) and DSM-IV diagnosed alcohol dependence is 
moderate (rg = 0.38)(13), reinforcing the notion that alcohol consumption cannot be used as 
a surrogate for alcohol dependence or AUD.
The Alcohol Use Disorders Identification Test (AUDIT) is a screening tool designed to 
identify hazardous alcohol use in the past year (14). The test consists of 10 items across 3 
dimensions pertaining to alcohol consumption (items 1–3, often termed AUDIT-C), 
dependence symptoms (items 4–6), and harmful alcohol use (items 7–10) (collectively 
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AUDIT-P). When the AUDIT was developed, a total score of 8 or higher was proposed to be 
indicative of harmful alcohol use (14) and a score of 20 or higher consistent with a diagnosis 
of alcohol dependence (15); however, there is no clear consensus and subsequent studies 
have suggested that additional factors including sex and cultural and social contexts should 
be considered when deriving thresholds for alcohol dependence (reviewed in Supplementary 
Table 1).
A recent population-based GWAS of AUDIT in 20,328 research participants from the 
genetics company 23andMe, Inc., identified a locus near the gene ADH1C (rs141973904; p 
= 4.4 × 10−7)(10) nominally associated with AUDIT total score. AUDIT scores among 
23andMe research participants were low and predominantly driven by alcohol consumption 
(AUDIT-C). The genetic correlation between AUDIT total score from 23andMe and alcohol 
consumption was much stronger (rg = 0.89, p = 9.01 × 10−10) than the genetic correlation 
between AUDIT total score and alcohol dependence (rg = 0.08; p = 0.65)(13).
In this study, we performed a GWAS meta-analysis using the UK Biobank (UKB; N = 
121,604) and the previously published 23andMe cohort (N = 20,328)(10), yielding the 
largest GWAS meta-analysis of AUDIT total score to date (N = 141,932). Using only the 
UKB cohort, we also sought to determine whether the alcohol consumption component of 
the AUDIT had a genetic architecture distinct from the dependence and harmful use 
components by performing GWASs of consumption “AUDIT-C” (items 1–3) and problems 
“AUDIT-P” (items 4–10). Linkage Disequilibrium Score regression (LDSC)(16) was used to 
calculate genetic correlations between AUDIT measures and other substance use, 
psychiatric, and behavioral traits. We also calculated genetic correlations with obesity and 
blood lipid traits, as these have previously been shown to associate with alcohol 
consumption (9, 10). We hypothesized that AUDIT-P would correlate more strongly with 
measures of hazardous substance use, including alcohol dependence, and other psychiatric 
conditions. Finally, in order to determine the thresholds for dichotomizing AUDIT total 
score that would most closely approximate alcohol dependence, we converted continuous 
AUDIT total score into cases and controls using different thresholds, performed GWAS on 
each, and calculated the genetic correlation with DSM-IV alcohol dependence (13).
Materials and Methods
UK Biobank sample
The UK Biobank (UKB) is a population-based sample of 502,629 individuals who were 
recruited from 22 assessment centers across the United Kingdom from 2006–2010 (17). 
157,366 individuals completed a mental health questionnaire as part of an online follow-up 
over a one-year period in 2017. The Alcohol Use Disorder Identification Test (AUDIT)(14) 
was administered to assess alcohol use over the past year, using gating logic (see 
Supplementary Figure 1). After performing quality control to remove participants with 
missing data, and keeping only white British unrelated individuals, 121,604 individuals with 
AUDIT total scores were available. AUDIT total score was created by taking the sum of 
items 1–10 for all participants, including those who endorsed currently never drinking 
alcohol (as they could still endorse past alcohol harm on items 9 and 10). We also created 
AUDIT subdomain scores by aggregating the scores from items 1–3, which include the 
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information pertaining to alcohol consumption (AUDIT-C, N = 121,604), and from items 4–
10, which indexes the information pertaining to alcohol problems (AUDIT-P, N = 121,604). 
These traits were log10 transformed to approximate a normal distribution (Supplementary 
Figure 2).
Genotyping, quality control and imputation
Genotype imputation was performed on 487,409 individuals by the UKB team using 
IMPUTE4 (18) and the Haplotype Reference Consortium reference panel. After quality 
control, 16,213,998 SNPs remained for GWAS analyses. Additional details on genotyping 
and quality control are shown in the Supplementary Material.
Discovery GWASs using UKB
GWAS analyses were performed using BGENIE v1.1 (18) with AUDIT scores (AUDIT total 
score, AUDIT-C, and AUDIT-P, tested independently) as the outcome variable and age, sex, 
genotyping array and the first 20 principal components derived from genotype data as 
covariates. See the Supplementary Material for extended details. In order to identify 
independently-associated variants (“index variants”), clump-based pruning was applied in 
FUMA using an r2 of 0.1 and a 1 Mb sliding window using the UKB White British sample 
as the LD reference panel. A 1 Mb window was used due to the regions of extended linkage 
disequilibrium on chromosomes 4q23 and 17q21.31, which were associated with AUDIT 
scores in this study.
In addition, we performed a series of 18 case-control GWAS analyses of AUDIT total score 
using different thresholds (cases: ≥8, 10, 12, 15, 18, 20 vs controls: ≤2, 3, 4). The sample 
size at each threshold is shown in Supplementary Table 2. The results of these analyses were 
used to determine which thresholds would produce the highest genetic correlation estimates 
with DSM-IV defined alcohol dependence (13).
SNP-Heritability analyses
The SNP-heritability of UKB AUDIT scores (total, AUDIT-C, AUDIT-P) was calculated 
using a genomic restricted maximum likelihood (GREML) method implemented in Genetic 
Complex Trait Analysis (GCTA)(19) on a subset of 117,072 unrelated individuals using a 
relatedness cut-off of 0.05 and controlling for age and sex. GREML analyses were run using 
genotyped SNPs with a MAF greater than 0.01 to construct the GRM.
GWAS meta-analysis of AUDIT total score using the UKB and 23andMe cohorts
Because the genetic correlation of AUDIT total score between the UKB and 23andMe 
cohorts was high (rg = 0.77, SE = 0.12, p = 7.15 × 10−11), we performed a sample-size 
based meta-analysis of AUDIT total score from the UKB and 23andMe cohorts using 
METAL (version 2011–03-25)(20). This meta-analysis comprises a total of 141,932 research 
participants of European ancestry and 9,519,872 genetic variants that passed quality control. 
We used clump-based pruning (see ‘Discovery GWAS’) to identify independently-associated 
variants. For each GWAS signal we defined a set of credible variants using a Bayesian 
refinement method developed by Maller et al. (21). These credible sets are considered to 
have a 99% probability of containing the ‘causal’ variant at each locus. Credible set analyses 
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were performed in R (https://github.com/hailianghuang/FM-summary) for each of the index 
variants associated with AUDIT total score in the GWAS meta-analysis using SNPs within 1 
Mb with an r2 >0.4 to the index variant. All downstream genetic analyses of AUDIT total 
score were performed using the GWAS meta-analysis summary statistics. The 23andMe 
AUDIT GWAS has previously been published (10) and 30,441 participants from the UKB 
cohort were included in a previous GWAS of alcohol consumption (9).The GWAS of alcohol 
consumption in UKB involved individuals genotyped during the first UKB data release (9). 
The individuals from UKB in the current study are those who completed the mental health 
questionnaire in 2017 and include those genotyped in both first and second UKB data 
release; the sample overlap between these two datasets is 30,441 individuals.
Functional mapping and annotation of GWAS meta-analysis
We used FUMA v1.2.8 (22) to study the functional consequences of the index SNPs, and of 
the SNPs contained in each credible set, which included ANNOVAR categories, Combined 
Annotation Dependent Depletion (CADD) scores, RegulomeDB scores, eQTLs, and 
chromatin states. We also studied the regulatory consequences of the index SNPs using the 
Variant Effect Predictor (VEP; Ensembl GRCh37).
Gene-set and pathway analyses
We performed MAGMA (22) competitive gene-set and pathway analyses using the summary 
statistics from the GWAS meta-analysis of AUDIT total score and the AUDIT-C and 
AUDIT-P subsets. SNPs were mapped to 18,546 protein-coding genes from Ensembl build 
85. Gene-sets were obtained from Msigdb v5.2 (“Curated gene sets”, “GO terms”).
Gene-based association using transcriptomic data with S-PrediXcan
We used S-PrediXcan (23) to predict gene expression levels in 10 brain tissues, and to test 
whether the predicted gene expression correlates with AUDIT scores. We used pre-
computed tissue weights from the Genotype-Tissue Expression (GTEx v7) project database 
(https://www.gtexportal.org/) as the reference transcriptome dataset. Further details are 
provided in the Supplementary Material.
Genetic correlation analysis
We used LD Score regression (LDSC) to identify genetic correlations between traits (24). 
This method was used to calculate genetic correlations (rg) between AUDIT total score, 
AUDIT-C, and AUDIT-P and 39 other traits and diseases (see Supplementary Tables 3, 4 and 
5). We did not constrain the intercepts in our analysis, as we could not quantify the exact 
amount of sample overlap between cohorts. We used False Discovery Rate (FDR) to correct 
for multiple testing (25). We also used LDSC to examine genetic correlations between 
various dichotomized versions of AUDIT and DSM-IV defined alcohol dependence (13). To 
test for significant differences between the genetic correlations, z-score statistics were 
calculated (see Supplementary Table 6).
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Results
UKB sample demographics and characteristics
In the UKB cohort, there were 121,604 individuals with AUDIT scores available for GWAS 
analysis (Supplementary Table 7). The UKB sample was 56.2% female (N = 68,389) and the 
mean age was 56.1 years (S.D. = 7.7). The mean AUDIT total score was 5.0 (S.D. = 4.18, 
range = 0–40); a histogram showing the distribution of the scores is shown in Supplementary 
Figure 2. Over the prior year, 91.9% of the participants reported drinking 1 or 2 drinks on a 
single day. Over the prior year, 6.3% of the participants reported they were not able to stop 
drinking once they started, and 10.7% felt guilt or remorse after drinking alcohol 
(Supplementary Table 7). Males had significantly higher AUDIT total mean scores than 
females (6.09 ± 4.45 vs. 4.15 ± 3.72, respectively; β = 0.47, p < 2 × 10−6; Supplementary 
Figure 3). In addition, age was negatively correlated with AUDIT scores (β = −0.02, p < 2 × 
10−6; Supplementary Table 8). Therefore, both sex and age were used as covariates in the 
GWAS analyses. The mean AUDIT-C score was 4.24 (S.D. = 2.83) and the mean AUDIT-P 
score was 0.75 (S.D. = 2.0). As expected, there was a moderate positive phenotypic 
correlation between AUDIT-C and AUDIT-P (r = 0.478, 95% C.I. = 0.473–0.481, p < 2 × 
10−16; Supplementary Table 8).
SNP-heritability in UKB
We estimated the SNP-heritability of AUDIT total score to be 12% (GCTA: ± 0.48%, p = 
4.6 × 10−273; LDSC: 8.6% ± 0.50%), which is similar to the estimate from Sanchez-Roige 
et al. (10). The SNP-heritability for AUDIT-C was 11% (GCTA: ±0.47%, p = 1.5 × 10−211; 
LDSC: 8.4% ±0.55%), and 9% for AUDIT-P (GCTA: ±0.46%, p = 2.0 × 10−178; LDSC: 
5.9% ±0.48%).
GWAS of AUDIT scores in UKB
The significant results (p < 5 × 10−8) of the GWAS of AUDIT total score in the UKB cohort 
are shown in Supplementary Table 9; this analysis revealed 12 independent GWAS signals 
located in 8 loci. The UKB GWAS of AUDIT-C and AUDIT-P subsets are summarized in 
Supplementary Tables 10 and 11 and Supplementary Figure 4. Seven of these 12 
independent GWAS signals also significantly associated with AUDIT-C; the same index 
variants were identified in the two analyses. An additional GWAS signal was also identified 
close to FNBP4. For AUDIT-P, 5 independent GWAS signals were significantly associated 
and these loci were also associated with the total AUDIT and AUDIT-C. The rs1229984 
SNP in ADH1B was not available for meta-analysis in the 23andMe sample and was not in 
Hardy Weinberg equilibrium (HWE) in the UKB sample used in the present study (p = 3.2 × 
10−16); however, in the total UKB White British sample there was no significant deviation 
from HWE (p = 0.13). The association between rs1229984 and AUDIT scores are presented 
in Supplementary Tables 9, 10 and 11. rs1229984 was strongly associated with all AUDIT 
scores in the UKB (β = 0.04–0.06, p ≤ 1.0 ×10−45), but this SNP was not included for 
clump-based pruning and downstream analyses. As such, we performed a conditional 
analysis of the SNPs on 4q23 and 4q24 in the UKB sample to determine whether any of 
these associations were significant after controlling for rs1229984 genotype. While 
rs13107325 on 4q24 remained significantly associated with AUDIT total score after 
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controlling for rs1229984 genotype, the association between rs146788033, rs11733695 and 
rs3114045 and AUDIT total score became non-significant, suggesting that these loci are 
tagging the strong rs1229984 signal in this region.
GWAS meta-analysis of AUDIT total score
The GWAS meta-analysis of the UKB and 23andMe samples found 15 independent GWAS 
signals (Supplementary Table 12) associated with AUDIT total score spanning 10 genomic 
loci (Table 1). Figure 1 shows the Manhattan and QQ plots of the GWAS meta-analysis of 
AUDIT total score and Supplementary Figures 5–14 show the regional association plots for 
the independent signals. The inflation factor of the meta-analysis GWAS was λGC = 1.22 
with an LDSC intercept of 1.008 (SE = 0.007), suggesting that the majority of the inflation 
is due to polygenicity. The 15 independent SNPs show 100% sign concordance for 
association with AUDIT total score across UKB and 23andMe (Table 1); 11 of these SNPs 
were nominally associated with AUDIT total score in 23andMe (p ≤ 0.05), and all index 
SNPs were associated with AUDIT total score in UKB (p < 1.8 × 10−6).
The top hit for the GWAS meta-analysis of AUDIT total score was a variant (rs11733695) 
located downstream (879 base pairs) from ADH6 (p = 3.4 × 10−30), which is a member of 
the alcohol dehydrogenase gene family.rs11733695 is in low LD (r2 = 0.17) with the 
functional SNP in ADH1B, rs1229984, which is known to alter alcohol metabolism (26). In 
addition, two other regions in 4q23 were associated with AUDIT total score in the meta-
analysis: one of the index SNPs was located in the ADH1C gene; however, conditional 
analysis of this region in UKB alone suggests that these multiple hits may in fact be tagging 
the rs1229984 signal. This region has been previously associated with alcohol consumption, 
AUD, and AUDIT scores (6, 7, 9, 10)
We also replicated the association between KLB (Supplementary Table 12), on chromosome 
4q14, and alcohol consumption (9, 11, 12); the index SNP rs11940694, which is located in 
the intron of KLB, was associated with AUDIT total score in the present study. Clump based 
pruning identified rs11940694 and rs4975012 as independent hits in the KLB region. 
Credible set analysis suggests that rs2046330 is the index SNP in the region represented by 
rs4975012 (Supplementary Table 13). AUDIT total score was also associated with SNPs that 
localized to GCKR on chromosome 2p23.3, which has been previously associated with 
alcohol consumption (9, 11). Five SNPs comprised the credible set at the GCKR locus, 
which also spans the SNX17 gene, including the missense variant (rs1260326) in GCKR that 
was identified as the index SNP.
We identified GWAS signals in several regions that have not been previously implicated in 
the genetics of AUD, including 2p21, 17q21, 3q25, 8q22, 10p11, 11p11 and 19q13. The 
index SNP rs13135092 in the 4q24 region is located in an intron of SLC39A8; the remainder 
of the credible set for this locus is located in a non-coding pseudogene, RN7SL728P. 
SLC39A8 is highly pleiotropic (27) but it is a novel association in relation to alcohol. A 
region of association on 2p21 contains 17 SNPs that are localized to the non-coding RNA, 
LINC01833. A novel region of association was also detected on chromosome 10p11.23; this 
region contains 9 credible SNPs that localize to the JCAD (junctional cadherin 5 associated) 
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gene. JCAD encodes an endothelial cell junction protein, and has previously been associated 
with coronary heart disease (28).
The remaining novel associations on 3q25, 8q, 11p11, 17q21 and 19q13.3 were more 
complex. The index variants on chromosome 8q22.1 were not localized to any genes, and it 
is unclear from the credible set analyses what the causal variants may be at these loci. The 
credible SNP sets for the 3q25.33, 11p11.2, 17q21.31 and 19q13.3 regions contained over 
50 SNPs each, which spanned several genes. For example, the index SNP on chromosome 
17q21.31 was an intronic SNP in MAPT, which encodes the tau protein and has been 
robustly associated with Parkinson’s disease (30, 31) (Supplementary Table 14) and other 
neurodegenerative tauopathies (32), and more recently with neuroticism (33). However, we 
note that the region of association on chromosome 17q21.31 spans the corticotrophin 
receptor gene (CRHR1), which has been associated with alcohol use in animals and humans 
(34). Thus, due to the extended complex LD in this region, we are unable to determine the 
likely causal variant. Similarly, the index SNP (rs2293576) at chromosome 11p11.2 is a 
synonymous SNP of the zinc transporter gene SLC39A13; however, this region includes 54 
associated SNPs, which map to five additional genes. Lastly, the index SNP on 19q13.3 is a 
synonymous variant in FUT2. FUT2 encodes galactoside 2-alpha-L-fucosyltransferase 2, 
which controls the expression of ABO blood group antigens. However, 70 SNPs form this 
credible set and they span 4 genes in total.
We used FUMA to functionally annotate all 1,290 SNPs in the credible sets (see 
Supplementary Table 13). The majority of the SNPs were intronic (76.9%; N = 993) or 
intergenic (11.6%; N = 149), while only 26 SNPs (2.0%) were exonic. Furthermore, 38 
SNPs showed CADD scores >12.37, which is the suggested threshold to be considered 
deleterious (35). The exonic SNPs (rs601338, rs17651549, rs13107325) of FUT2, MAPT 
and SLC39A8, respectively, had the highest CADD scores (>34), suggesting potential 
deleterious protein effects. 164 SNPs had RegulomeDB scores of 1a-1f, showing evidence of 
potential regulatory effects. 90.1% of the SNPs were in open chromatin regions (minimum 
chromatin state 1–7).
Gene-based and pathway analyses
We used MAGMA (22) to perform a gene-based association analysis; which identified 40 
genes that were significantly associated with AUDIT total score (p < 2.70 × 10−6; 
Supplementary Table 15, Supplementary Figure 15). As expected, the majority of these 
genes were in the 10 GWAS loci (i.e. KLB, GCKR); DRD2 and CRHR1 were also among 
the top hits. In addition, the analysis revealed a strong burden signal in CADM2 (p = 1.64 × 
10−9), where the index variant in GWAS meta-analysis did not reach genome-wide 
significance. We did not identify any canonical pathways that were significantly associated 
with AUDIT (Supplementary Table 16).
Gene-based (MAGMA) analyses for the AUDIT-C and AUDIT-P subsets (Supplementary 
Figures 16 and 17, respectively) revealed evidence of overlap (Supplementary Figure 18, 
Supplementary Table 17). Two genes (KLB, CADM2) were associated with all 3 AUDIT 
traits (AUDIT total score, AUDIT-C, and AUDIT-P). There was considerable overlap 
between AUDIT total score and AUDIT-C, with 21 overlapping genes associated at the 
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gene-based level. Only one gene, DRD2, was associated with both AUDIT total score and 
AUDIT-P.
S-PrediXcan
S-PrediXcan identified a positive correlation (p < 1.07 × 10−6) between AUDIT total score 
and the predicted expression of 26 genes across multiple brain tissues (full results are 
presented in Supplementary Table 18), including MAPT (cerebellum), FUT2 (caudate and 
nucleus accumbens), and CRHR1-IT1 (putamen, cerebellum, hippocampus, anterior 
cingulate cortex). SNPs in the region of MAPT and FUT2 were associated with AUDIT total 
score in the GWAS. MAPT (cerebellum), FUT2 (nucleus accumbens) and CRHR1-IT1 
(caudate, cortex, nucleus accumbens, hypothalamus, hippocampus) were also associated 
with AUDIT-C (Supplementary Tables 19). S-PrediXcan for AUDIT-C and AUDIT-P 
(Supplementary Table 20) revealed that lower predicted RFC1 expression in the cerebellum 
and hemisphere, respectively, was associated with higher scores on both AUDIT-C (p = 7.84 
× 10−7) and AUDIT-P (p = 1.54 × 10−6).
Genetic correlations
We used LDSC to evaluate evidence for genetic correlations between our three primary traits 
(AUDIT total score, AUDIT-C, and AUDIT-P) and numerous other traits for which GWAS 
summary statistics were available; these included alcohol and substance use traits, 
personality and behavioral traits, psychiatric disorders, blood lipids, and brain structure 
volumes (Supplementary Tables 3–5 and Figure 2).
As expected, AUDIT-C and AUDIT-P were highly genetically correlated (rg = 0.70, p = 4.1 
× 10−70). AUDIT scores (AUDIT total score, AUDIT-C, and AUDIT-P) showed strong 
genetic correlations with alcohol consumption from two other studies (rg = 0.76–0.96, p < 
2.3 × 10−9). Many of the genetic correlations with AUDIT-P were significantly different 
from the correlations with AUDIT-C (Supplementary Table 6). The AUDIT-C had a 
significantly stronger (p = 8.02 × 10−3) correlation with alcohol consumption (rg = 0.92, p = 
7.0 × 10−164) than did AUDIT-P (rg = 0.76, p = 2.7 × 10−52). In contrast, AUDIT total and 
AUDIT-C scores were only modestly correlated with alcohol dependence (rg = 0.39 and 0.33 
respectively, p < 8.2 × 10−5), whereas AUDIT-P showed a nominally stronger genetic 
correlation with alcohol dependence (rg = 0.63, p = 1.8 × 10−8; AUDIT-P vs AUDIT-C, p = 
0.033; see Supplementary Table 6).
We detected positive genetic correlations between AUDIT scores (AUDIT total, AUDIT-C, 
AUDIT-P) and other substance use phenotypes, including lifetime smoking (rg = 0.24–0.41, 
p < 1.6 × 10−5) and cannabis use (rg = 0.26–0.46, p < 1.1 × 10−4). We also observed a 
positive genetic correlation between AUDIT-P and cigarettes per day (rg = 0.28, p = 4.0 × 
10−3).
Several psychiatric disorders and related traits were positively genetically correlated with 
AUDIT-P scores, including schizophrenia (rg = 0.22, p = 3.0 × 10−10), bipolar disorder (rg = 
0.26, p = 1.5 × 10−4), ADHD (rg = 0.23, p = 1.1 × 10−5), and major depressive disorder 
(MDD, rg = 0.26, p = 5.6 × 10−3). Intriguingly, AUDIT-C was negatively correlated with 
Sanchez-Roige et al. Page 9
Am J Psychiatry. Author manuscript; available in PMC 2020 February 01.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
MDD (rg = −0.23, p = 3.7 × 10−3) and ADHD (rg = −0.10, p = 1.8 × 10−2), whereas AUDIT-
P showed positive genetic correlations with these same disease traits (rg = 0.26, p = 5.6 × 
10−3; rg = 0.24, p = 1.1 × 10−5). We observed a positive genetic correlation between AUDIT-
P scores and depressive symptoms (rg = 0.30, p = 3.0 × 10−8) and neuroticism (rg = 0.18, p = 
2.6 × 10−4), and a negative genetic correlation with subjective well-being (rg = −0.24, p = 
4.0 × 10−5).
We observed positive genetic correlations between AUDIT total score, AUDIT-C and 
education, college attainment, and cognitive ability (rg = 0.19–0.24, p < 1.5 × 10−5). The 
AUDIT-P genetic correlations with the same education and college attainment were near 
zero, and were significantly lower than AUDIT C and AUDIT total or education traits 
(Supplementary Table 6).
There were negative genetic correlations between AUDIT total and AUDIT-C scores and 
obesity (rg = −0.16–0.17, p < 1.1 × 10−5), similar to previous reports regarding AUDIT total 
score (10) and alcohol consumption (9). In contrast, obesity was not significantly genetically 
correlated with AUDIT-P scores (rg = 0.01, p = 0.90). Similarly, HDL cholesterol and 
triglycerides were genetically correlated with AUDIT total score and AUDIT-C (rg = 0.19–
22, p < 9.3 × 10−5, rg = −0.16, p < 1.0 × 10−4 respectively), but this association was not 
found for AUDIT-P (rg = 0.11, p = 2.2 × 10−2, rg = −0.03, p = 6.4 × 10−1). Obesity showed 
significantly different correlations with both AUDIT-P and AUDIT-C (Supplementary Table 
6)
Dichotomizing AUDIT total score to more closely approximate alcohol dependence
As AUDIT can be rapidly ascertained in large populations, we explored methods for 
dichotomizing AUDIT total score that optimized the genetic correlation with DSM-IV 
alcohol dependence (13). Higher genetic correlations with alcohol dependence were 
observed as the control threshold was increased from 2 to 4, and with increasingly stringent 
case cut-offs (Figure 3 and Supplementary Table 2). The highest genetic correlation was 
observed for cases with AUDIT total score ≥20 and controls ≤4 (rg = 0.90, SE = 0.25, p = 
3.0 × 10−4), however, this highly stringent threshold produced very few cases (N=1,290). 
The standard error of the estimate is much larger at more stringent case thresholds and 
therefore these estimates should be interpreted with caution. Defining cases as ≥12 yielded 
an rg of 0.82 (SE = 0.18, p = 3.2 × 10−6) while retaining more than 7 times as many cases 
(N=9,130), these genetic correlations were not significantly different from those obtained 
using cases ≥20 and controls ≤4 (p = 0.80).
Discussion
We have presented the largest GWAS meta-analysis of AUDIT total score to date, using 
large population-based cohorts from UKB and 23andMe. We identified novel associations 
with AUDIT total score; the genes located in these regions include JCAD and SLC39A8. We 
found evidence for association in several loci previously associated with alcohol use via 
single-variant and gene-based analyses (i.e. KLB, GCKR, CADM2). The SNP heritability of 
all AUDIT phenotypes ranged from 9–12% demonstrating that common genetic factors 
account for a prominent proportion of the variation in alcohol use phenotypes. Furthermore, 
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we showed that there is shared genetic architecture between AUDIT scores and other alcohol 
and substance use phenotypes. AUDIT-P showed a positive genetic correlation with several 
psychiatric diseases, distinguishing AUDIT-P from AUDIT-C. Finally, using LDSC, we 
identified thresholds for dichotomizing AUDIT total score (AUDIT score ≥12 to define 
cases, and ≤4 to define controls) that maximize the genetic correlation with alcohol 
dependence while retaining a large number of participants.
Our top GWAS hits replicated previous association signals for alcohol use traits. The 
strongest associations with AUDIT score in this study spanned the alcohol metabolism genes 
on chromosome 4q23 (10). Variants in this region were associated with AUDIT total score, 
AUDIT-C and AUDIT-P, demonstrating that alcohol metabolism is a risk factor for both 
alcohol consumption and problematic use. The second strongest signal, also associated with 
the three AUDIT phenotypes, is located in KLB, confirming the robust association of this 
gene with both alcohol consumption (9, 11, 12) in humans, and in mice (12). However, the 
biology of this locus could be more complex than previously described. Although the 
credible set analysis suggested that the more probable causal variants are all located on the 
first intron of KLB, one of these variants, rs11940694, is an eQTL for RFC1 expression in 
the brain, and S-PrediXcan analysis predicted that lower expression of RFC1 in the brain is 
associated with higher predicted AUDIT (AUDIT-C and AUDIT-P) scores. Interestingly, a 
gene in the complex GWAS signal on chromosome 19, Fibroblast growth factor 21 (FGF21), 
was associated with AUDIT (AUDIT total score, AUDIT-C, AUDIT-P) at the gene-based 
level (Supplementary Table 17). FGF21 regulates sweet and alcohol preference in mice as 
part of a receptor complex with β-Klotho (KLB) in the central nervous system (33). 
Additionally, we replicated the association between rs1260326 in the gene GCKR and 
alcohol consumption (9, 11), here associated with AUDIT total score and AUDIT-C. Other 
loci previously associated with alcohol consumption include CADM2 (9), which was 
associated at the gene-based level for all three AUDIT traits. Here, the burden analysis 
suggests that multiple (rare and common) variants are necessary to explain the association 
signal. Intriguingly, several of the novel associations with AUDIT scores were mapped to 
highly pleiotropic genes (MAPT, FUT2, SLC39A8)(27).
Genetic analysis of the AUDIT subsets revealed evidence of distinct genetic architecture 
between AUDIT-C and AUDIT-P (alcohol consumption vs. problem use), with support from 
the gene-based (Supplementary Figures 16 and 17), S-PrediXcan (Supplementary Tables 19 
and 20), and genetic correlation analyses (Figure 2). Furthermore, AUDIT-P showed a strong 
genetic correlation with alcohol dependence (13). In contrast, AUDIT-C had a stronger 
genetic correlation with alcohol consumption. Thus, partitioning AUDIT scores into 
different subsets (alcohol consumption vs problem use) may disentangle genetic factors that 
contribute to different aspects of AUD vulnerability.
Genetic overlap was observed for all measures of AUDIT and other substance use traits, 
including lifetime tobacco and cannabis use, as we previously reported (10, 36, 37), 
demonstrating that genetic risk factors for high AUDIT scores overlap with increased 
consumption of multiple drug types.
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We found several significant differences between the genetic correlations with AUDIT-P and 
AUDIT-C. These differences were particularly pronounced for psychiatric and behavioral 
traits. AUDIT-P was positively genetically correlated with psychopathology (schizophrenia, 
bipolar disorder, MDD, ADHD), personality traits including neuroticism, and regional brain 
volumes. These associations have previously been observed at the phenotypic level; AUDs 
commonly co-occur in individuals with schizophrenia (38), bipolar disorder (39), MDD (40) 
and adult ADHD (41). Intriguingly, genetic risk for high AUDIT-C score was negatively 
correlated with MDD and ADHD demonstrating that a distinct genetic component of 
AUDIT-P is shared with genetic risk for psychiatric disease. Regional volume abnormalities 
in subcortical brain regions of AUD individuals have been reported (42–44), however, it is 
unclear whether these alterations are a result of high alcohol drinking or a pre-existing 
susceptibility. We identified a positive genetic correlation between AUDIT-P and increased 
caudate volume; however, the majority of studies report reductions in regional brain volumes 
associated with AUD.
For AUDIT total score and AUDIT-C we showed positive genetic correlations with 
educational attainment and cognitive ability and negative genetic correlations with obesity, 
consistent with earlier reports (9, 10). These associations were not observed for AUDIT-P. 
Similarly, HDL cholesterol showed a significant positive correlation, and triglycerides a 
negative correlation, with AUDIT total score and AUDIT-C, but not AUDIT-P. These 
patterns were previously observed for alcohol consumption (9). We could speculate that 
these differences may be linked to socioeconomic status (SES). Alcohol consumption is 
often higher in individuals with higher SES (45), whereas alcohol-related problems, such as 
binge drinking (46) and alcohol related mortality (47), are more prevalent in individuals with 
lower SES. Furthermore, individuals with low SES are more likely to have AUDs with 
psychiatric co-morbidities (48). Consistent with this idea, we find positive genetic 
correlations between AUDIT-C and education, a trait correlated with SES (49), and positive 
genetic correlations between AUDIT-P and psychopathology. Our findings provide further 
evidence that different dimensions of alcohol use associate differently with behavior and that 
these differences may have a biological underpinning.
A clinical diagnosis of AUD is often required to define cases for genetic studies. An 
alternative strategy would be to use AUDIT to infer AUD case status; however, it has not 
been clear whether and how to perform meta-analyses between AUDIT scores and alcohol 
dependence. A GWAS meta-analysis for AUDIT and alcohol dependence could be 
simplified if a threshold could be used to define cases and controls based on AUDIT scores, 
an approach that was used by Mbarek et al. (50). We have provided empirical evidence about 
genetic correlations between AUDIT and alcohol dependence using dichotomized AUDIT 
scores, and found thresholds for AUDIT that produced high genetic correlations with AUD 
(Figure 3). Genetic correlations increased as the upper threshold for cases was made more 
stringent, although the standard errors for all of these estimates were overlapping. The 
genetic correlation with alcohol dependence appeared to asymptote when case status was 
defined as ≥12; therefore, this threshold could be used to define case status. We also 
considered various thresholds for defining controls and found that ≤4 produced a high 
genetic correlation with alcohol dependence while also retaining the largest number of 
subjects.
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Our study is not without limitations. AUDIT specifically asks about the past year, and thus 
may not capture information on lifetime alcohol use and misuse. This is suboptimal for 
genetic studies because it effectively measures a recent state rather than a stable trait. 
Measures capturing drinking and AUD across the lifespan may be preferable. Also, although 
mean scores for the AUDIT-C dimension were 4.24, the mean of the AUDIT-P dimension 
was considerably lower (0.75). Thus, we were not able to perform a more refined 
categorization (e.g. 3 subsets: consumption [items 1–3], dependence [items 4–6], hazardous 
use [items 7–10]) as fewer individuals endorsed the items comprising AUDIT-P (see 
Supplementary Table 7). Furthermore, our study uses data from UKB and 23andMe research 
participants, who were volunteers not ascertained for AUD, and hence our findings may not 
generalize to other populations showing higher rates of alcohol use and dependence. 
Additional alcohol-related phenotypes (e.g. age at first use; patterns of alcohol drinking, 
including binge drinking) could be used in subsequent genetic studies to identify additional 
sources of genetic vulnerability for AUD. Lastly, we offered guidelines to identify cases to 
use in genetic studies of AUD (i.e. AUDIT score ≥12) based on genetic correlations; 
however, these recommendations are not intended to determine thresholds for diagnosing 
dependence in a clinical setting. Future studies will be able to test whether using AUDIT as 
a surrogate for AUD will be beneficial for gene discovery. In addition, several studies have 
argued that lower thresholds should be used for females, which has not been addressed in the 
present study.
We have reported the largest GWAS of AUDIT ever undertaken. We replicated previously 
identified signals (i.e. ADH1B, ADH1C; KLB; GCKR), and identified novel GWAS signal 
(i.e. JACD, SLC39A8) associated with AUDIT. We show that different portions of the 
AUDIT (AUDIT-C, AUDIT-P) correlate with distinct traits, which will aid in dissecting 
genetic vulnerability towards alcohol use and dependence. The genetic factors that 
predispose to high alcohol consumption inevitably overlap with those for problem drinking, 
as heavy drinking is generally a prerequisite for the development of hazardous use and 
dependence. However, not everyone who consumes alcohol experiences the same level of 
harmful consequences. By studying the different subsets of AUDIT, we identify genetic 
factors that may be specific to problem drinking. Larger studies of cohorts with a wider 
range of AUDIT-P scores are required to both replicate and expand these findings. Finally, 
we describe an alternative strategy to rigorous ascertainment for genetic studies of AUD, i.e. 
AUDIT score ≥12 to define cases and ≤4 to define controls, which could be used to achieve 
large sample sizes in a cost-efficient manner.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Figure 1. 
Manhattan and QQ plots for the SNP-based GWAS meta-analysis of AUDIT total score (N = 
141,932)
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Figure 2. 
Genetic correlations between the three AUDIT phenotypes (total score, AUDIT-C, AUDIT-
P) and several traits measured in independent cohorts as described in the Supplementary 
Tables 3–5: alcohol-related traits, tobacco and cannabis use, neuropsychiatric, personality, 
cognition, anthropomorphic and blood lipids. ADHD, attention-deficit/hyper-activity 
disorder; BMI, body mass index; SE, standard error; IQ, intelligence quotient; HDL, high-
density lipoprotein. * p < 0.05, ** p < 0.01, *** p < 0.0001; # AUDIT-P vs AUDIT-C, p < 
0.01 FDR 5%, (#) AUDIT-P vs AUDIT-C, p < 0.05
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Figure 3. 
Genetic correlations between AUDIT cases (8 [N = 25,423], 10 [N = 15,151], 12 [N = 
9,130], 15 [N = 4,471], 18 [N = 2,099], 20 [N = 1,290]) vs controls (2, 3, 4) in the UK 
Biobank and DSM-IV derived alcohol dependence from the Psychiatric Genetics 
Consortium. The orange line is a visualization of the number of cases used at each threshold, 
corresponding to the N on the right hand y-axis.
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